Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication.
Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication.
复制标题
DOI:
10.3390/v14050869
复制
发表时间:
2022-04-22
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
We previously isolated an HSV-1 mutant, KOS-NA, that contains two non-synonymous mutations in UL39. One of the mutations, resulting in an R950H amino acid substitution in ICP6, renders KOS-NA severely neuro-attenuated and significantly reduces HSV-1 latency. Vaccination of mice with KOS-NA prior to corneal challenge provides significant protection against HSV-1-mediated eye diseases even at a very low immunizing dose, indicating its utility as a vaccine scaffold. Because KOS-NA contains a neuro-attenuating mutation in a single gene, we sought to improve its safety by deleting a portion of the UL29 gene whose protein product, ICP8, is essential for viral DNA replication. Whereas KOS-NA reduced replication of HSV-1 challenge virus in the corneal epithelium and protected mice against blepharitis and keratitis induced by the challenge virus, KOS-NA/8- and an ICP8- virus were significantly less efficacious except at higher doses. Our results suggest that the capacity to replicate, even at significantly reduced levels compared with wild-type HSV-1, may be an important feature of an effective vaccine. Means to improve safety of attenuated viruses as vaccines without compromising efficacy should be sought.
登录
查看更多内容
影响因子:
3.7
作者:
Naidu, Shan K.;Nabi, Rafiq;Kousoulas, Konstantin G.
通讯作者:
Kousoulas, Konstantin G.
影响因子:
5.4
作者:
GAO, M;KNIPE, DM
通讯作者:
KNIPE, DM
影响因子:
6.4
作者:
Hoshino, Yo;Pesnicak, Lesley;Cohen, Jeffrey I.
通讯作者:
Cohen, Jeffrey I.
影响因子:
5.5
作者:
Hook, Lauren M.;Awasthi, Sita;Friedman, Harvey M.
通讯作者:
Friedman, Harvey M.
影响因子:
3.7
作者:
Morrison, LA;Da Costa, XJ;Knipe, DM
通讯作者:
Knipe, DM